Table 1.
Group | Sample size | Chemotherapy protocol | Patient neoplasm type | Chemotherapy schedule (days) | Follow up schedule (days) |
---|---|---|---|---|---|
G-I | 45 | Vinorelbine | Metastatic breast cancer | 1, 7, 14, 21 | 6, 13, 20, 28 |
NSCL Cancer | 1, 7, 14, 21 | 6, 13, 20, 28 | |||
G-II | 15 | Vinorelbine/Doxurubicin | Metastatic breast cancer | 1, 8 | 7, 15 |
Vinorelbine/Cisplatin | NSCL Cancer | 1, 8 | 7, 15 | ||
Cervix Cancer | 1, 8 | 7, 15 |